Benzinga | May 5, 2021 04:44PM EDT

Sarepta Therapeutics Q1 EPS $(2.10) Misses $(1.78) Estimate, Sales $146.93M Beat $143.33M Estimate

Sarepta Therapeutics (NASDAQ:SRPT) reported quarterly losses of $(2.10) per share which missed the analyst consensus estimate of $(1.78) by 17.98 percent. This is a 101.92 percent decrease over losses of $(1.04) per share from the same period last year. The company reported quarterly sales of $146.93 million which beat the analyst consensus estimate of $143.33 million by 2.51 percent. This is a 29.26 percent increase over sales of $113.67 million the same period last year.